Drug Manufacturers Send Counteroffers as Medicare Price Negotiations Continue, HHS Says
- March 08, 2024
All pharmaceutical manufacturers whose drugs were one of the ten selected for the first round of the new Medicare drug price negotiation program have returned counteroffers, the Department of Health and Human Services reported March 4.
ARTICLE TAGS
You must be logged in to access this content.